UMGCC Paul Calabresi Clinical Oncology Training Program

描述（由申请人提供）：马里兰州大学玛琳和斯图尔特格林鲍姆癌症中心（UMCCC）保罗卡拉布雷西临床肿瘤学培训计划将支持职业发展和卡拉布雷西学者在临床肿瘤学转化研究的培训。UMCCC Calabresi学者将拥有医学博士学位，D.O.，或同等临床学位，已完成临床培训，并准备为初级教师任命。此外，博士、药学博士或拥有博士学位的注册护士谁已经完成了至少一个博士后的经验，谁是致力于临床肿瘤转化研究的职业生涯是合格的。在UMCCC学者计划中推广的主题反映了UMCCC的优势领域：癌症的多模式治疗策略;药物发现和开发;以及在服务不足的少数民族人群中的临床癌症研究。该计划将提供一个教学学习经验，导致科学在临床研究硕士;临床研究经验，将集中在每个学者的癌症治疗相关的临床试验的发展，以回答基于假设的临床研究问题与翻译终点;和一个基础/人口科学活动，这将与临床协议翻译问题。每位学者将通过指导委员会（由一名临床导师、一名基础/人口科学导师和一名生物统计导师组成）协助学者实现这些目标。此外，将为每个学者成立一个独立的资助申请开发委员会，与学者导师委员会无关，以促进学者成功获得独立的同行评审资金。UMCCC计划的特点包括：1）来自巴尔的摩马里兰州大学五所专业学校的参与和支持（医学，药学，护理，牙科和法律的UMB学校）; 2）经验丰富，资金充足的多学科导师; 3）UM现有的K30临床研究课程的强度为Calabresi学者的教学培训; 4）与现有的K12密切协调和资源共享，特别是UM多学科临床研究职业发展奖; 5）临床研究基地，由超过150个开放和累积的临床试验组成，反映多学科临床专业知识和机构承诺支持临床研究。

DESCRIPTION (provided by applicant): The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) Paul Calabresi Clinical Oncology Training Program will support career development and training of Calabresi Scholars in clinical oncology translational research. UMGCC Calabresi Scholars will have an M.D., D.O., or equivalent clinical degree, have finished clinical training, and be ready for a junior faculty appointment. In addition, Ph.D.s, Pharm.D.s, or R.N.s with a Ph.D. who have finished at least one post-doctoral experience and who are committing to a career in clinical oncology translational research are eligible. The themes to be promoted in the UMGCC Scholars Program reflect areas of UMGCC strength: multimodality treatment strategies for cancer; drug discovery and development; and clinical cancer research in underserved minority populations. The Program will provide a didactic learning experience leading to a Master of Science in Clinical Research; a clinical research experience that will focus each Scholar's development of a cancer therapy - related clinical trial to answer a hypothesis-based clinical research question with translational endpoints; and a basic/population science activity which will tie to the clinical protocol translational question. The Scholars will be assisted in these goals by each Scholar having a Mentorship Committee consisting of a Clinical Mentor, a Basic/Population Science Mentor, and a Biostatistical Mentor. In addition, an independent Grant Application Development Committee will be formed for each Scholar, unrelated to the Scholar's Mentor Committee, to promote success of the Scholar in securing independent, peer reviewed funding. The UMGCC Program is distinguished by a number of features including 1) participation and support from five professional Schools at the University of Maryland, Baltimore (UMB Schools of Medicine, Pharmacy, Nursing, Dental, and Law); 2) experienced, well-funded multidisciplinary mentors; 3) the strength of UM's existing K30 Clinical Research Curriculum for the Calabresi Scholars' didactic training; 4) close coordination and the sharing of resources with existing K12s, particularly the UM Multidisciplinary Clinical Research Career Development Award; 5) a clinical research base consisting of >150 open and accruing clinical trials reflecting multidisciplinary clinical expertise and Institutional commitment to support clinical research.